Profit taking weighs down ImmunoGen

Investors locked in profits on ImmunoGen Inc. (Nasdaq: IMGN). The stock price tumbled $1.33 to $14.11.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.